Lintitript是一种高效、选择性、口服活性的竞争性非肽类 CCK1 受体拮抗剂，具有极强的亲和力，EC₅₀ 为 6 nM，Ki 为 0.2 nM。其对 CCK1 受体的选择性比 CCK2 受体高 33 倍以上（EC₅₀ 为 200 nM）。Lintitript 能提高血浆中的瘦素水平，促进食物摄入，同时增加胰岛素的血浆浓度。

Pentagastrin (ICI-50123) is a selective agonist of Cholecystokinin B (CCKB) receptor with an IC50 of 11 nM. Pentagastrin is a synthetic polypeptide that has effects like gastrin when given parenterally, which can cause the secretion and synthesis of salivary proteins.

WAY-620645是一种 CCK 拮抗剂，具有抗肿瘤和镇痛活性。

Loxiglumide is a cholecystokinin (CCK) receptor antagonist.

Gastrin I is an endogenous gastrointestinal peptide hormone that can bind to cholecystokinin (CCK) receptors.

Nastorazepide is a selective, orally available, 1,5-benzodiazepine-derivative gastrin/cholecystokinin 2 (CCK-2) receptor antagonist with potential antineoplastic activity.

Ceruletide 是一种十肽，也是一种有效的胆囊收缩素受体激动剂。Ceruletide 是一种安全且有效的促胆囊收缩剂，具有直接作用于胆囊肌肉和胆管的痉挛效应。

Rebamipide is an inducer of endogenous prostaglandin, an oxygen-derived free radical scavenger, and a cholecystokinin type 1 (CCK1) receptor inhibitor for inhibiting [125I]BH-CCK-8S with IC50 of 37.7 μM.